Merit Medical Systems Inc
NASDAQ:MMSI

Watchlist Manager
Merit Medical Systems Inc Logo
Merit Medical Systems Inc
NASDAQ:MMSI
Watchlist
Price: 105.33 USD 0.29% Market Closed
Market Cap: 6.1B USD
Have any thoughts about
Merit Medical Systems Inc?
Write Note

Merit Medical Systems Inc
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Merit Medical Systems Inc
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Merit Medical Systems Inc
NASDAQ:MMSI
Deferred Income Tax
$5.6m
CAGR 3-Years
-45%
CAGR 5-Years
-37%
CAGR 10-Years
9%
Haemonetics Corp
NYSE:HAE
Deferred Income Tax
$62.9m
CAGR 3-Years
37%
CAGR 5-Years
40%
CAGR 10-Years
9%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Deferred Income Tax
$193m
CAGR 3-Years
-22%
CAGR 5-Years
-17%
CAGR 10-Years
-1%
ICU Medical Inc
NASDAQ:ICUI
Deferred Income Tax
$48.5m
CAGR 3-Years
206%
CAGR 5-Years
133%
CAGR 10-Years
27%
Align Technology Inc
NASDAQ:ALGN
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lantheus Holdings Inc
NASDAQ:LNTH
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Merit Medical Systems Inc
Glance View

Market Cap
6.1B USD
Industry
Health Care

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 6,446 full-time employees. The Company’s segments include cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. The endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products, including peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer and endoscopy.

MMSI Intrinsic Value
87.16 USD
Overvaluation 17%
Intrinsic Value
Price

See Also

What is Merit Medical Systems Inc's Deferred Income Tax?
Deferred Income Tax
5.6m USD

Based on the financial report for Sep 30, 2024, Merit Medical Systems Inc's Deferred Income Tax amounts to 5.6m USD.

What is Merit Medical Systems Inc's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
9%

Over the last year, the Deferred Income Tax growth was -70%. The average annual Deferred Income Tax growth rates for Merit Medical Systems Inc have been -45% over the past three years , -37% over the past five years , and 9% over the past ten years .

Back to Top